Project Grant K23NS133497

Award Date 9/1/24
Completion Date 8/31/29
Dollars Obligated $215K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30329, USA
Similar Awards
This $365,000 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development of novel cellular systems for modeling DYT1 dystonia using patient-derived neurons. The key objective is to investigate the molecular pathogenesis of DYT1 dystonia, a severe hereditary movement disorder, by examining how dysregulation of the nuclear...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,503,949 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Rockefeller University. The grant, awarded on May 1, 2025, supports a research project titled "Applying RNA Logic in Space and Time to Neurologic Disease". The project aims to develop new techniques and concepts to discover therapeutic targets for neurological diseases by studying...
Emory University received a $430,375 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to elucidate the subcellular dynamics of ubiquitination, a key biological process regulating synaptic function and neuronal health, using advanced single-molecule imaging techniques. The research aims to uncover new mechanisms by...
This federal Project Grant award of $596,570.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders, is focused on improving the sensitivity and specificity of diffusion MRI (dMRI) techniques. The key objectives are to: Develop and validate improved methods for sub-voxel fiber identification and tissue characterization using dMRI, with the goal of overcoming limitations in...
This $563,343 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, supports research conducted by New York University (NYU) to investigate the physical, molecular, and cellular mechanisms underlying tissue guidance and tissue splitting during nervous system development. The research uses the posterior lateral line primordium migration in zebrafish as...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services, awarded a $4,528,840 Project Grant to The Salk Institute For Biological Studies under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The three-year award beginning August 19, 2022 will fund research to functionally dissect cerebellar output circuits that orchestrate limb motor control. Specifically, the grantee will...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $846,469 to Brandeis University to develop new visualization and manipulation tools for studying the dynamics of the endosomal sorting complex required for transport (ESCRT) machinery in neurons. The research aims to elucidate how ESCRT complexes are regulated and deployed in...
This federal Project Grant award of $163,184, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by New York University (NYU) to investigate the relationship between speech planning deficits and neurological disorders such as Parkinson's disease (PD). The research aims to dissect the function of the caudal middle frontal gyrus (CMFG), a...
This Project Grant award from the National Institutes of Health National Institute of Neurological Disorders and Stroke provides $4,036,400 to Drexel University to support research investigating immune modulating therapies for the treatment of Complex Regional Pain Syndrome (CRPS). The award period is from September 30, 2022 through August 31, 2025. The grant funds research aimed at elucidating mechanisms of T cell dysfunction in CRPS and investigating novel immune modulating therapies....
This federal Project Grant award, identified as F31NS137765, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $173,140 grant, awarded on Sep 30, 2024, supports research to investigate the role of neural activity in the degeneration of midbrain dopamine neurons, which is a key pathological process in Parkinson's disease. The project will utilize...

This $214,785 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program will support research led by Dr. Laura Scorr at Emory University to define the role of immune mechanisms in cervical dystonia. The key products and services to be delivered under this 5-year award include:

Analyzing immune cell frequencies, delineating indices of altered immune cell function and activation, and comparing histopathologic markers of immune activation in the brains of individuals with cervical dystonia compared to healthy controls. This research strategy will enable Dr. Scorr to build expertise in neuroimmunology, quantitative neuroanatomical methods, and bioinformatics/data science to identify potential pathogenic pathways for cervical dystonia. The findings could inform the development of improved diagnostic tools and novel therapeutics for this disabling neurological disorder.

Generated 7/1/25, 3:03 AM